Johnson & Johnson (NYSE:JNJ) is not only a Dividend Aristocrat, it is also a Dividend King. The 51 Dividend Aristocrats are a group of companies in the S&P 500 Index, with 25+ consecutive years of dividend increases. The Dividend Kings …
Johnson & Johnson (NYSE: JNJ) stock first traded back in 1944. For the first 58 years of the company's existence, it was privately held by the Johnson family. J&J stock has been a big winner throughout the years, but never more so …
When you look back at the way that Johnson & Johnson seemed to make its decisions to split its shares, the process closely resembles what you'd see from a number of other companies. Broadly speaking, when the share price climbed …
The first thing I do when analyzing a stock to determine whether it's a buy is to study the competitive advantages of the underlying business. Johnson & Johnson excels in this regard. The healthcare colossus combines the most …
Pfizer Inc. (ticker: PFE) and Johnson & Johnson (JNJ) are two of the largest health care stocks and drugmakers in the world, each with a market capitalization north of $200 billion. Both of their shares are up over the past year, both are …
Tyler Durden: Perhaps the only chart more troubling than Johnson & Johnson’s (NYSE:JNJ) stock price in 2015, …
“Caring for the world, one person at a time…inspires and unites the people of Johnson & Johnson. We embrace research and science – bringing innovative ideas, products and services to advance the health and well-being of people. Our …
At Johnson & Johnson, the world’s largest health care company, products or business that aren’t top performers aren’t lasting very long. About 70 percent of sales come from assets that were either No. 1 or No. 2 in their category. Last …
Under the ASR agreements Janssen Pharmaceutical will purchase shares of Johnson & Johnson common stock that the banks will have borrowed from stock lenders, and during the term of the ASR agreements the banks are expected to …